Arcutis

Arcutis Biotherapeutics

This biopharmaceutical company develops and commercialises topical treatments for patients with chronic inflammatory skin diseases such as psoriasis, eczema, and seborrhoeic dermatitis.

DICE Therapeutics

This biopharmaceutical company develops oral small molecule medicines for patients with chronic immunological and inflammatory diseases such as psoriasis.

Dermira

This biopharmaceutical company develops and commercialises medical dermatology treatments for patients with chronic skin conditions such as excessive sweating and atopic dermatitis.

Alumis

This company develops oral therapies and precision medicines for patients with immune-mediated disorders including plaque psoriasis and systemic lupus erythematosus.

Krystal Biotech

This biotechnology company develops and commercialises redosable gene therapies for patients with rare genetic diseases, including dystrophic epidermolysis bullosa.

Evelo Biosciences

This biotechnology company develops orally delivered microbial medicines targeting the small intestinal axis to treat patients with inflammatory diseases like psoriasis and atopic dermatitis.

Zerigo Health

This company develops a handheld phototherapy device and smartphone app for patients to treat chronic skin conditions at home using narrowband UVB light.

DermBiont

This clinical-stage biotechnology company develops targeted topical therapeutics to treat skin diseases, such as hyperpigmentation and seborrheic keratoses, for patients with dermatological conditions.